Sentence examples for underperforms expectations from inspiring English sources

However, if growth significantly underperforms expectations over the coming months, the flexibility of the fiscal framework should be utilised".

"If growth significantly underperforms expectations over the coming months," the statement from the O.E.C.D. continued, "the flexibility of the fiscal framework should be utilised".

"However, if growth significantly underperforms expectations over the coming months, the flexibility of the fiscal framework should be utilised". The UK is one quarter of negative growth away from entering a triple-dip recession after official figures for the last three months of 2012 showed that the economy shrank by 0.3%.

Simply put, platform investments prioritizing technical means over business ends typically underperform expectations and impact.

"There is very little room now to stimulate the economy if it continues to underperform expectations".

That said, investors remain particularly sensitive to both macro economic data and company earnings, and with Intel, JP Morgan, Citigroup and Bank of America all reporting next week, traders could be a little jumpy, particularly if one of these companies underperform expectations.

The US economy has underperformed expectations, which slows down everyone; room for monetary and fiscal loosening is constrained; and Argentina and Venezuela have both suffered the consequences of their own policy errors.Some of these 2014 forecasts will doubtless get upgraded again before the year is out.

I think this line of argument could use a little work.9 59: My impression so far, with Sestak, Bennet and Giannoulias looking OK in early polls, and Manchin and Coons through, is that the Republicans are going to underperform expectations in the Senate, but may overperform in the House.

And if earnings underperform expectations?

Nominee Newt is a frightening thought for Republican partisan commentators but Mitt Romney continues to underperform expectations.

Provenge was hailed as breakthrough for the cell therapy industry [ 1] but ultimately a combination of manufacturing and marketing challenges, combined with the emergence of more affordable and less complicated competition led it to underperform expectations [ 34, 35].